Mabuterol Hydrochloride

盐酸马布特罗

Report date: 2022/07/27 14:32:53
NME

Base Information

Drug NameMabuterol Hydrochloride
Drug Alias Name马布特罗BroncholinPB-868KF-868DS
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsAirway ObstructionPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesKaken Pharmaceutical Co Ltd
Inactive CompaniesShenyang Pharmaceutical Dalei Yunshang Pharmaceutical Co Ltd
Active IndicationsAirway ObstructionPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeR03CC
Related LinksKEGG